Supriya Pharmaceuticals (Delisted) results and financials
BSE: 524784
Delisted on 23 Aug 2017.
Results
Standalone; ₹ crore, the charts by years to September, the table by quarter.Quarterly results
Quarter to Jun 2008, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹0.03 Cr0.00%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹0.02 CrQuarter to Mar 2008: −₹0.02 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −56.7%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
| ₹ crore | Sep 2007 | Dec 2007 | Mar 2008 | Jun 2008 |
|---|---|---|---|---|
| Revenue | 0.04 | 0.03 | 0.03 | 0.03 |
| Net profit | −0.02 | −0.02 | −0.02 | −0.02 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −44.7% | −63.3% | −56.7% | −56.7% |
Standalone. The 4 quarters from Sep 2007, the first on record. The latest is shaded.
Company details
- Legal name
- Supriya Pharmaceuticals Ltd.
- BSE code
- 524784
- ISIN
- INE647C01016
- Listed
- Jan 2001
- Face value
- ₹10
- CIN
- L24232RJ1985PLC003363
- Corporate identity number, the registrar of companies' code for it